| Literature DB >> 34830021 |
Corina Popovici1,2, Cristina-Maria Pavel3, Valeriu Sunel1, Corina Cheptea4, Dan Gheorghe Dimitriu3, Dana Ortansa Dorohoi3, Diana David5, Valentina Closca3,6, Marcel Popa2.
Abstract
Original results are presented in the field of research that addresses the extension of the reaction of residue of acyl-thiosemicarbazide fixation on the structure of 5-nitrobenzimidazole by a sulphonic group. The aim of the study is the increase of new thiosemicarbazide derivatives' applicative potential in the field of biochemistry, with a wide range of medical applications. The newly obtained compounds were characterized by using elemental analysis and spectral analysis (FT-IR and 1H NMR). A study regarding the optimization of the chemical reactions was made. The performed in vitro biological tests confirmed the tuberculostatic activity of three newly obtained compounds against Mycobacterium tuberculosis.Entities:
Keywords: 2-mercapto-benzimidazole; heterocyclic thiosemicarbazides; sulfonic derivatives; tuberculostatic activity
Mesh:
Substances:
Year: 2021 PMID: 34830021 PMCID: PMC8622382 DOI: 10.3390/ijms222212139
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Scheme 1The synthesis of 5-nitro-benzimidazole-2-yl-mercapto-acetic acid (I).
Scheme 2Synthesis of 5-nitrobenzimidazole-2-yl-sulphonyl-acetic acid (II).
Scheme 3Synthesis of 5-nitrobenzimidazole-2-yl-sulphonyl-acetic acid ethyl ester (III).
Scheme 4The synthesis of 5-nitrobenzimidazole-2-yl-sulphonyl-acetic acid hydrazide (IV).
Scheme 5Synthesis of 1-(5′-nitrobenzimidazole-2′-yl-sulphonyl-acetyl)-4-aryl-thiosemicarbazides (V–VII).
Figure 1The FT-IR spectra of 1-(5′-nitrobenzimidazole-2′-yl-sulphonyl-acetyl)-4-(p-methoxyphenyl)-thiosemicarbazide (VII).
Figure 21H-NMR spectra of 1-(5′-nitrobenzimidazole-2′-yl-sulphonyl-acetyl)-4-(p-methoxyphenyl)-thiosemicarbazide (VII).
Dimensionless variables and the measured reaction’s yield for obtaining the compound V.
| No. |
|
|
| |||
|---|---|---|---|---|---|---|
| 1 | –1 (64) | –1 (2.5) | 1 | 1/3 | 1/3 | 72 |
| 2 | –1 (64) | 0 (3) | 0 | 1/3 | –2/3 | 76 |
| 3 | –1 (64) | 1 (3.5) | –1 | 1/3 | 1/3 | 70 |
| 4 | 0 (64.5) | –1 (2.5) | 0 | –2/3 | 1/3 | 76 |
| 5 | 0 (64.5) | 0 (3) | 0 | –2/3 | –2/3 | 80 |
| 6 | 0 (64.5) | 1 (3.5) | 0 | –2/3 | 1/3 | 77 |
| 7 | 1 (65) | –1 (2.5) | –1 | 1/3 | 1/3 | 75 |
| 8 | 1 (65) | 0 (3) | 0 | 1/3 | –2/3 | 76 |
| 9 | 1 (65) | 1 (3.5) | 1 | 1/3 | 1/3 | 72 |
Dimensionless variables and the measured reaction’s yield for obtaining the compound VI.
| No. |
|
|
| |||
|---|---|---|---|---|---|---|
| 1 | –1 (64) | –1 (3.0) | 1 | 1/3 | 1/3 | 80 |
| 2 | –1 (64) | 0 (3.5) | 0 | 1/3 | –2/3 | 83 |
| 3 | –1 (64) | 1 (4.0) | –1 | 1/3 | 1/3 | 78 |
| 4 | 0 (64.5) | –1 (3.0) | 0 | –2/3 | 1/3 | 82 |
| 5 | 0 (64.5) | 0 (3.5) | 0 | –2/3 | –2/3 | 84 |
| 6 | 0 (64.5) | 1 (4.0) | 0 | –2/3 | 1/3 | 83 |
| 7 | 1 (65) | –1 (3.0) | –1 | 1/3 | 1/3 | 79 |
| 8 | 1 (65) | 0 (3.5) | 0 | 1/3 | –2/3 | 82 |
| 9 | 1 (65) | 1 (4.0) | 1 | 1/3 | 1/3 | 78 |
Dimensionless variables and the measured reaction’s yield for obtaining the compound VII.
| No. |
|
|
| |||
|---|---|---|---|---|---|---|
| 1 | –1 (64) | –1 (3.5) | 1 | 1/3 | 1/3 | 84 |
| 2 | –1 (64) | 0 (4.0) | 0 | 1/3 | –2/3 | 88 |
| 3 | –1 (64) | 1 (4.5) | –1 | 1/3 | 1/3 | 83 |
| 4 | 0 (64.5) | –1 (3.5) | 0 | –2/3 | 1/3 | 86 |
| 5 | 0 (64.5) | 0 (4.0) | 0 | –2/3 | –2/3 | 89 |
| 6 | 0 (64.5) | 1 (4.5) | 0 | –2/3 | 1/3 | 85 |
| 7 | 1 (65) | –1 (3.5) | –1 | 1/3 | 1/3 | 84 |
| 8 | 1 (65) | 0 (4.0) | 0 | 1/3 | –2/3 | 87 |
| 9 | 1 (65) | 1 (4.5) | 1 | 1/3 | 1/3 | 83 |
Figure 3Dependence of the reaction’s yield on the dimensionless variables in optimization process of reactions from Scheme 5. for the compounds: (a) V; (b) VI; (c) VII.
The most favorable conditions for obtaining the compounds V–VII.
| Compound | |||
|---|---|---|---|
|
| 0.11 (64.55) | –0.09 (3 h 57 min 18 s) | 79.83 |
|
| –0.05 (64.47) | 0.11 (3 h 33 min 25 s) | 84.22 |
|
| –0.05 (64.47) | –0.07 (3 h 57 min 54 s) | 89.24 |
Tuberculostatic activity of thiosemicarbazides V–VII against Mycobacterium tuberculosis, in vitro compared to isoniazid (IAH).
| Compound | The Concentration of Thiosemicarbazides in the Culture Medium (μg/mL) | MIC (μg/mL) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5 | 10 | 20 | 30 | 40 | |||||||
| 6 | 15 | 6 | 15 | 6 | 15 | 6 | 15 | 6 | 15 | ||
|
| ++ | +++ | ++ | ++ | ++ | + | – | – | – | – | 35 |
|
| ++ | +++ | ++ | + | – | – | – | – | – | – | 20 |
|
| ++ | +++ | + | – | – | – | – | – | – | – | 15 |
|
| – | – | – | – | – | – | – | – | – | – | 10 |